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 Accumulating evidence suggests a critical role for the unfolded protein response (UPR) 
in multiple sclerosis (MS) and in its animal model, experimental autoimmune 
encephalomyelitis (EAE). In this study, we investigated the relevance of activating 
transcription factor 6α (ATF6α), an upstream regulator of part of the UPR, in EAE. The 
expressions of ATF6α-target molecular chaperones such as glucose-regulated protein 78 
(GRP78) and glucose-regulated protein 94 (GRP94) were enhanced in the acute inflammatory 
phase after induction of EAE. Deletion of Atf6 suppressed the accumulation of T cells and 
microglia/macrophages in the spinal cord, and ameliorated the clinical course and 
demyelination after EAE induction. In contrast to the phenotypes in the spinal cord, activation 
status of T cells in the peripheral tissues or in the culture system was not different between two 
genotypes. Bone marrow transfer (BMT) experiments and adoptive transfer of autoimmune 
CD4+ T cells to recipient mice (passive EAE) also revealed that CNS-resident cells are 
responsible for the phenotypes observed in Atf6α-/- mice. Further experiments with cultured 
cells indicated that inflammatory response was reduced in Atf6α-/- microglia, but not in Atf6α-/- 
astrocytes, and was associated with proteasome-dependent degradation of NF-κB p65. Thus, 






Multiple sclerosis (MS) is the most common autoimmune disease of the central 
nervous system (CNS) that affects approximately 2.5 million people worldwide (Compston et 
al., 2008). Both MS and its well-studied murine model, experimental autoimmune 
encephalomyelitis (EAE), are characterized by extensive immune cell infiltration leading to 
inflammation, gliosis, demyelination, and eventual neurodegeneration (Dendrou et al., 2015). 
MS/EAE is mediated by activated autoreactive myelin-specific CD4+ T cells that enter the 
CNS. However, recent evidence has suggested that a broader range of cells from both the 
innate and adaptive immune systems, as well as glial cells in the CNS, may contribute to the 
development of its pathology (Duffy et al, 2014). Among these, resident-microglia and 
infiltrating macrophages produce a plethora of neurotoxic inflammatory mediators such as 
cytokines, chemokines, and reactive oxygen species, and are now considered as key players in 
MS/EAE pathogenesis (Friese et al., 2014; Xiao et al., 2013).  
It is well-documented that under conditions such as inflammation, cells show rapidly 
increased rates of protein synthesis, resulting in the accumulation of unfolded proteins in the 
endoplasmic reticulum (ER) (Zhang and Kaufman, 2008; Kitamura, 2011). This buildup of 
unfolded proteins results in ER stress and activates the unfolded protein response (UPR). The 
UPR is composed of three transducers: Protein kinase R (PKR)-like endoplasmic reticulum 
kinase (PERK), inositol-requiring enzyme 1 (Ire1), and activating transcription factor 6 
(ATF6) (Mori, 2009; Walter and Ron, 2011). PERK-downstream events include 
phosphorylation of the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α), which 
suppresses global protein synthesis to reduce protein loads into the ER and paradoxically 
enhances the translation of activating transcription factor 4 (ATF4), which upregulates the 




IRE1 and ATF6 include molecular chaperones in the ER, such as glucose-regulated 
protein78 (GRP78) and glucose-regulated protein 94 (GRP94). 
Accumulating evidence has suggested a crucial role for the UPR in the pathogenesis 
of various myelin disorders including MS, Pelizaeus-Merzbacher Disease (PMD), and their 
animal models (for review, Lin and Popko, 2009; Stone and Lin, 2015). PMD is an X 
chromosome -linked demyelinating disease which is caused by mutations in the gene 
proteolipid protein-1 (PLP1). Activation of the UPR was observed in the white matter of PMD 
patient and PLP1-mutant mice, and also in the transfected fibroblasts expressing mutant 
protein (Southwood et al., 2002). Interestingly, the CHOP protein, which had been known as a 
pro-apoptotic transcription factor, exhibited protective activity on the oligodendrocytes in the 
PLP1-mutant mice (Southwood et al., 2002). Consistent with the observations in PMD, 
enhanced level of the UPR marker proteins was observed in multiple cell types of both MS 
patients (Mháille, et al., 2008) and EAE mice (Ni Fhlathartaigh, et al., 2013). Recent studies 
have further demonstrated important roles for PERK on oligodendrocytes. Differential effects 
of interferon-γ (IFN-γ) on demyelination were mediated, at least in part, by activation of 
PERK-eIF2α pathway in oligodendrocytes (Lin et al., 2006; Lin et al., 2007). Moderate PERK 
activation was protective on oligodendrocytes in the models of MS (Lin et al., 2013; Lin et al., 
2014), and, consistently, oligodendrocyte-specific PERK deletion increased the susceptibility 
of mice to EAE (Hussien et al., 2014). Although the importance of the PERK pathway in 
MS/EAE is being revealed, the role of other UPR pathways remains unknown.  
In the current study, we sought to dissect the role of ATF6 during EAE pathogenesis. 
We found that the ATF6 pathway is activated in the spinal cords at the acute phase of EAE. 
Surprisingly, deletion of Atf6 ameliorated demyelination, inflammation, and EAE severity. 
Atf6  deficiency did not affect immune response in the peripheral tissues, but repressed 




degradation of NF-κB p65 in microglia. Our data indicate for the first time that ATF6 is 




Materials and Methods  
 
Mice and induction of EAE  All animal experiments were approved by the Animal Care and 
Use Committee of Kanazawa University (AP-153485). Atf6α+/- mice were generated as 
previously described (Yamamoto et al. 2007), and backcrossed with the C57BL/6 strain more 
than 8 times in the Institute of Laboratory Animals Graduate School of Medicine, Kyoto 
University. Atf6+/- mice were then intercrossed to obtain Wild-type (WT) and Atf6α-/- mice, 
and maintained by mating mice with same genotypes (WT male and WT female mice, or 
Atf6-/- male and Atf6-/- female mice) in the Institute for experimental animals, Kanazawa 
University Advanced science research center. 
Male mice (aged 7–10 weeks and weighing 20–25 g) were used for the experiments. GFP 
transgenic mice in the C57BL/6 strain were kindly provided by Dr. Ikawa from Osaka 
University, Japan (Okabe et al., 1997). Active and passive EAE were induced in mice as 
described preciously (Stromnes and Goverman, 2006A; Stromnes and Goverman, 2006B). For 
active EAE, mice were subcutaneously injected with 200 μl of an emulsion (1:1 ratio of PBS 
and complete Freund’s adjuvant (CFA, Chondrex, Inc., Redmond, WA) containing 100g of 
myelin oligodendrocyte glycoprotein peptide 35-55 (MOG35-55) (GL Biochem (Shanghai) Ltd., 
Shanghai, China). At 0 h and 48 h after immunization, mice were intraperitoneally injected 
with 200 ng of pertussis toxin (List Biological Laboratories, Campbell, CA). Samples from the 
acute and chronic phases were taken from day 14 to 17 and from day 40 to 50 after induction of 
EAE, respectively. For adoptive transfer of autoimmune CD4+ cells to recipient mice (passive 
EAE), mice were immunized with MOG35-55 peptide in CFA, and at day 9, the spleen and 
draining lymph nodes (inguinal, proper axillary and accessory axillary) were harvested. The 
pooled cells (3–4 × 106 cells/ml) were restimulated with 20 g/ml of MOG, and IL-2 (40 U/ml, 




incubation, CD4+ cells were isolated by negative selection using the CD4+ cells isolation kit 
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). These cells (7 × 106 cells/250 l PBS) 
were intravenously injected into sublethally irradiated (480 Gy) mice. Mice were scored for 
clinical severity, as previously described (Miller et al., 2010). Score 0=normal, Score 1=limp 
tail or hind limb weakness, but not both, Score 2=limp tail and hind limb weakness, Score 
3=partial hind limb paralysis, Score 4=complete hind limb paralysis, Score 5=moribund or 
death by EAE.  
 
Bone marrow transfer (BMT)  Bone marrow chimeras were generated as described 
previously (Xiao et al., 2013). In brief, mice were lethally irradiated (9.8 Gy, 0.5 Gy/min), and 
after 20 h, bone marrow cells (107 cells/100 μl) derived from GFP-transgenic mice, were 
infused by intravenous injection. After 8 weeks, the chimeric mice were induced for active 
EAE as described above. 
  
Isolation of mononuclear cells from tissues  Mononuclear cells from the spleen and lymph 
nodes were prepared by homogenizing tissues through a cell strainer (BD, Franklin Lakes, NJ), 
followed by treatment with ACK lysing buffer (Thermo Fisher Scientific, Waltham, MA). 
Mononuclear cells from the brain and spinal cord were isolated as described previously 
(Schattling et al., 2012). In brief, mice were perfused with HBSS, and the brain and spinal cord 
were removed. They were minced and digested in collagenase (Sigma, St. Louis, MO) solution 
containing DNAseI (Sigma) for 45 min at 37°C. After triturating through the cell strainer (BD), 
the tissue was resuspended in 30% of Percoll (GE Healthcare, Little Chalfont, 
Buckinghamshire, UK) and layered underneath 70% Percoll. After centrifugation (1,500 g, 30 





Flow cytometry and cell proliferation assay Leukocyte subsets were identified by 
staining the cells with monoclonal antibodies against the following proteins: CD3e (145-2C11, 
1:100; eBioscience, San Diego, CA), CD4 (GK1.5, 1:100; Tonbo Bioscience, San Diego, CA), 
CD8a (53-6.7, 1:100; eBioscience), CD11b (M1/70, 1:100; Biolegend, San Diego, CA), B220 
(RA3-6B2, 1:100; BD), CD45 (30-F11, 1:100; eBioscience),  IFN-γ (XMG1.2, 1:100; 
eBioscience), IL-17A (eBio17B7, 1:100; eBioscience), TNFα (MP6-XT22, 1:100; 
eBioscience), and NOS2 (CXNFT, 1:100; eBioscience). Intracellular cytokine staining was 
performed as described previously (Jäger et al., 2009). In brief, cells were stimulated for 4.5 h 
with 50 ng/ml PMA (Sigma) and 1 μM ionomycin (Sigma) in the presence of GolgiStop (BD). 
Cells were then fixed and permeabilized using the Intracellular Fixation and Permeabilization 
Buffer Set (eBioscience). Cells were analyzed for cytokine production by staining with 
anti-cytokine Abs. Flow cytometry was performed using the GalliosTM flow cytometer 
(Beckman Coulter, Indianapolis IN), and data were analyzed using the Kaluza software 
(Beckman Coulter) or Flowjo software (Tree Star, Ashland, OR). Cell proliferation was 
measured as described previously (Muramatsu et al., 2011). In brief, on day 10 after EAE 
induction, splenocytes and lymphocytes were isolated from the spleen and lymph node, 
respectively. Cells were re-stimulated with MOG35-55 for 3 days, and then subjected to the 
BrdU incorporation assay (CycLex Co., LTD, Nagano, Japan). 
 
Quantitative real time RT-PCR (qRT-PCR)  Total RNA was extracted from the 
lumbar spinal cord of each mouse using RNeasy® Lipid Tissue Mini Kit (Qiagen, Valencia, 
CA), and from cultured microglia or astrocytes using the RNeasy® mini Kit (Qiagen). RT 
reactions containing 1 g of total RNA were performed using PrimeScriptTM (Takara, Otsu, 
Shiga, Japan). Individual cDNA was amplified with THUNDERBIRDTM SYBR qPCR® Mix 




Nos2 (iNOS), Ccl2, Ccl8, Mmp9, and Gapdh, as described below. The comparative Ct method 
was used for data analyses with MxPro 4.10 (Agilent Technologies, Santa Clara, CA). Values 
for each gene were normalized to Gapdh expression levels. Primer sequences for qPCR: Atf6α, 
GTCTCATTTCGAAGGGATCAT and AGTCCTGCCCATTGATCACA; sXbp-1, 
TAGAAAGAAAGCCCGGATGA and CTCTGGGGAAGGACATTTGA; Hspa5, 
ATGGTATTCTCCGAGTGACA  and GCTTTCCAGCCATTCAATCT; Nos2 
AGAATGTGACCATCATGGAC and GAGGGACCAGCCAAATCCAGT;  Ccl2
 CCAGCAAGATGATCCCAATG and TCTGGACCCATTCCTTCTTG; Ccl8 
AGCCTTGAACCTTCACACCTGAGT and CCAGGCACCATCTGCTTGTAACAT; Gapdh 
AGGTCGGTGTGAACGGATTTG and TGTAGACCATGTAGTTGAGGTCA 
 
Western blot   Samples from the lumbar spinal cords or from cultured cells were 
solubilized in a buffer containing 1% NP40, 0.1% SDS, and 0.2% deoxycholate. Solubilized 
samples were subjected to western blotting with the following antibodies: KDEL (StressGen, 
Victoria, British Columbia, Canada), p38 (StressMarq Biosciences Inc., Victoria, BC, Canada), 
JNK (Santa Cruz Biotechnology, Inc., Dallas, TX), p-JNK, p-p38, ERK1/2, p-ERK1/2, p65, 
p-p65, IκB, and p-IKK/ (Cell signaling technology, Danvers, MA), GAPDH (Wako, 
Osaka City, Osaka, Japan). Primary antibody binding was visualized using the ECL system 
(GE Healthcare Bio-Sciences Corp., Piscataway, NJ).  
 
Histology and immunohistochemistry Lumbar spinal cords were dissected from mice 
after perfusion with 4% paraformaldehyde, and cross-sections (10-m thick for cryosections 
and 4-μm thick for paraffin sections) were cut on a cryostat or a microtome. Sections were 
processed for hematoxylin-eosin (H&E) staining or for immunohistochemistry with the 




GFAP (Dako, Glostrup, Denmark), Iba1 (Wako), CD45, CD4 (BD), p65, and GFP (MBL, 
Nagoya City, Aichi, Japan). In some cases, cell nuclei were visualized with DAPI (Sigma). 
Cy3-labeled- and Alexa 488-labeled-IgG were used as secondary antibodies. Confocal images 
were obtained by using Nikkon EZ-C1.  
 
Cell culture  Microglia and astrocytes were isolated from the cerebral cortex of 1–3-d-old 
neonatal mice following previously described methods with minor modifications (McCarthy 
and Vellis, 1980; Giulian and Baker, 1985). Briefly, cerebral hemispheres were harvested from 
neonatal mice, and the meninges were carefully removed. Brain tissue was then digested at 
37ºC in HEPES-buffered saline containing Dispase II (2 mg/mL; Wako). Cells were 
resuspended in DMEM (Sigma) supplemented with 10% fetal bovine serum, and plated in T75 
culture flasks (Corning Inc., Corning, NY) at the density of two brains/flask. After a 10-d 
cultivation period, microglia and astrocytes were separated by shaking (200 rpm, 20 h). 
Microglia were harvested from the floating cell populations, and plated at a density of 8 x104 
cells/well in 8 chamber slides (WATSON CO., Kobe, Hyogo, Japan) or 6 x105 cells/well in 6 
well culture plates (Corning Inc.). Astrocytes were obtained from adherent cell populations, 
and plated at a density of 5 x105 cells/well in 6 well culture plates. The isolated microglia and 
astrocytes were used for experiments after 24 h incubation and after achieving confluence, 
respectively. Cells were treated with LPS (100 ng/ml; Sigma), IL-1 (100 ng/ml; Wako) or 
TNF (20 ng/ml; Wako) for the indicated times. In some cases, cells were also treated with 
MG132 (10 M; Sigma), a proteasomal inhibitor for the indicated times. 
 
NF-κB nuclear translocation   Translocation of NF-κB p65 was analyzed as previously 
described (Goldmann et al., 2013).  Briefly, cultured microglia in 8 chamber slides were 




4% paraformaldehyde containing 0.2% of NP-40. Cells were subjected to 
immunocytochemistry with antibodies against Iba1 and p65. Cell nuclei were visualized with 
DAPI (Sigma). Confocal images were obtained by using Nikkon EZ-C1. 
 
NF-κB transcription activity  Activation status of NF-κB was measured using 
TransAM® NFκB p65 Chemi Kit (Active motif, Carlsbad, CA)(Renard et al., 2001). Briefly, 
nuclear extract was performed using cultured microglia stimulated with LPS or maintained in 
the medium alone, according to the manufacture’s protocol. Nuclear proteins (10g) were 
added to a 96 well plate containing an immobilized oligonucleotide corresponding site 
(5’-GGGACTTTCC-3’). After 1 h incubation at room temperature, an antibody against an 
epitope of the p65 subunit of NF-κB was added, and incubated again for 1h at room 
temparature. Further incubation with peroxidase-conjugated secondary antibody and with a 
developing solution resulted in chemiluminescence. Positive and negative control were made 
using a nuclear extract of Jurkat cells provided by the manufacture and through competitive 
binding with a wild-type consensus sequence, also provided by the manufacture. The addition 
of a mutant consensus oligonucleotide did not have any effect on NF-κB binding.  
 
Image Quantification and statistical analysis Quantification of western blots, 
immunohistochemistry and immunocytochemistry images was performed using Image J. To 
quantify demyelination, the MBP-negative area in each section was measured at 10x 
magnification, and calculated as percentage of entire section area. The number of 
microglia/macrophage was counted for cells with Iba1+ and DAPI+ images. Evaluation of the 
nuclear fluorescence in cultured microglia was performed as previously described (McCloy et 
al., 2014), using the total corrected cellular fluorescence (TCCF) which was calculated by 




readings).   Statistical analyses were performed using the Student’s t-test or analysis of 






ATF6 pathway is activated at the acute phase of EAE. 
 We first evaluated the activation status of the UPR during the time course of EAE. 
qRT-PCR analysis revealed that Atf6 expression increased and reached a peak at the acute 
phase of EAE (Fig. 1A). Similarly, the expression of spliced Xbp1, which encodes the activated 
form of XBP1, a transcription factor in the IRE1 pathway operating in concert with ATF6 to 
regulate the downstream genes such as molecular chaperones, ERAD and membrane 
synthesizing proteins, also increased at this period. In contrast, the expression of Ddit3 
(CHOP), a downstream molecule of PERK, was elevated at the chronic phase of EAE (Fig. 1A). 
These data indicate that all three branches of the UPR are activated after EAE, even though 
their contribution to EAE pathogenesis might be different (Fig. 1A). Western blot analysis 
confirmed the peak of the expression of ATF6-target molecules such as GRP94 and GRP78 
in the acute phase of EAE (Fig. 1B, Fig. S1).  
Molecular chaperones in the ER including GRP78 and GRP94 have a common KDEL 
amino acid sequence at their C-terminals, and the anti-KDEL antibody has been used to 
analyze their expression (Takano et al., 2007; Kezuka et al., 2015). In order to determine the 
activation status of ATF6 in EAE lesions, we performed immunohistochemistry for KDEL 
(Fig. 1C), together with that for cell-specific markers (Fig. 1D). In normal (control) condition, 
KDEL expression was observed predominantly in the gray matter (Fig. 1C). However, once 
mice were induced with EAE (acute phase), high level of KDEL expression was observed in 
the white matter (Fig. 1C). KDEL-expressing cells in the control condition included neurons 
(data not shown) and oligodendrocytes (Fig. 1D), while those in the EAE condition included 




oligodendrocytes in the white matter (Fig. 1D), as previously reported (Ni Fhlathartaigh, et al., 
2013).  
 
Atf6α deficiency ameliorates EAE severity. 
 To investigate whether Atf6α plays a role in the pathogenesis of EAE, we compared 
phenotypes between wild-type (WT) and Atf6α-/- mice after induction of EAE. In the 
physiological condition, there was no gross difference between WT and Atf6α-/- mice in the 
spinal cord (data not shown). However, after induction of EAE, Atf6α-/- mice developed milder 
clinical symptoms that were characterized by a decrease in the score of paralysis (Fig. 2A). All 
12 WT mice and 12 out of 13 Atf6α-/- mice (92.3%) developed EAE, and 3 out of 12 WT mice 
(24%) and 1 out of 13 Atf6α-/- mice (7.7%) died in the acute phase of EAE. Consistent with the 
clinical scores, histological and immunohistochemical analysis revealed that the infiltration 
level of inflammatory cells and demyelination was lower in the spinal cord of Atf6α-/- mice, 
compared with that of WT mice (Fig. 2B, C, S5). Flow cytometry analysis demonstrated that 
this phenotype in Atf6α-/- mice was associated with a lower number of CNS (brain and spinal 
cord)-infiltrating CD4+ and CD8+ T cells (Fig. 2D). In addition, among the CD4+ T cells, the 
number of pathogenic TH1 (IFN-γ+) cells were lower in the CNS of Atf6α-/- mice, although that 
of TH17 (IL-17A+) cells was not significantly different between two genotypes (Fig. 2E, F).  
 
Activation of T cells is not affected by Atf6α deficiency in the peripheral tissues or in the culture 
system. 
 The efficient activation of T cells is critical for induction of EAE. To study whether 
deletion of Atf6α affects this, we characterized peripheral lymphocytes in both genotypes. 
Interestingly,  there was no significant difference between WT and Atf6α-/- mice in the number 




pathogenic TH1 and TH17 cells (Fig. S2 B) either in the spleen or in the lymph nodes after EAE 
induction. We further isolated lymphocytes from immunized mice and tested the in vitro recall 
response upon secondary exposure to MOG35-55 peptide. T cells derived from Atf6α-/- mice did 
not show an impaired recall response to MOG35-55 compared to WT mice, as assessed by 
measurement of proliferation (Fig. S3 C). These data suggested that deletion of Atf6α does not 
impair T cell activation.  
 
Activation of microglia/macrophages is impaired in Atf6α-/- mice after EAE. 
 Ample evidence has demonstrated that gliosis is one of the earliest signs of EAE and 
correlates strongly with the recruitment of immune cells, demyelination, and clinical severity 
(Davalos et al., 2012). Therefore, we examined whether deletion of Atf6α caused any changes 
in microgliosis and astrogliosis after EAE induction. Immunohistochemical analysis of the 
spinal cord revealed no gross morphological differences between WT and Atf6α-/- mice in the 
resting microglia under control conditions (Fig. 3A, Control). These types of microglia are 
characterized by small cell bodies with long, thin ramified processes. After EAE induction, 
however, either the activated microglia or infiltrating macrophages, which are defined as 
enlarged cell bodies with short and thick processes, were observed to a lesser extent in the 
white matter of the spinal cord in Atf6α-/- mice (Fig. 3A, EAE). In contrast, we observed similar 
levels of astroglial activation, which was characterized by enlarged cell bodies with thick 
processes, after EAE in both WT and Atf6α-/- mice (Fig. S3 A).  
 Activated microglia/macrophages contribute to inflammation, demyelination, and 
neuronal damage in EAE by releasing a number of potentially toxic substances, including nitric 
oxide (NO) synthesized by inducible nitric oxide synthase (iNOS, also known as NOS2, 
Lowenstein et al., 2004). Therefore, we next investigated NOS2 expression levels in the CNS 




NOS2 expression in CD11b+ CD45locells, which represent microglia, but not in CD11b+ 
CD45hi cells, which represent invading macrophages, was significantly lower in Atf6α-/- mice 
compared with WT mice after EAE induction (Fig. 3B). Consistent with these data, we found 
significantly lower levels of p65 subunit of NF-κB, a major transcription factor required for 
NOS2 expression, in the microglia/macrophages from Atf6α-/- mice (Fig. 3C).  
 
ATF6α in the CNS-resident cells regulates EAE severity. 
 In order to analyze whether ATF6α in the CNS-resident cells plays an essential role in 
regulating EAE severity, we employed the radiation bone marrow chimeric mice (termed here 
as BM chimera) and the transfer of WT- and Atf6α-deficient- CD4+ T cells to WT mice 
(passive EAE). BM chimeras were generated by reconstituting lethally irradiated WT or 
Atf6α-/- mice with WT bone marrow cells isolated from GFP-transgenic mice. In BM chimeras, 
the peripheral immune system is comprised entirely of BM-donor-derived cells, whereas all 
CNS-resident microglia remain of host-origin because microglia do not turnover after 
irradiation and BM reconstitution (Hickey et al., 1992). Our results revealed that lack of Atf6α 
expression within the CNS (GFP+WT→ Atf6α-/-) indeed decreased EAE severity compared to 
chimeric mice that express Atf6α in resident CNS cells (GFP+WT→WT) (Fig. 4A). This milder 
phenotype correlated with a lower level of infiltration of GFP-positive BM-donor-derived cells 
in GFP+WT→ Atf6α-/- mice (Fig. 4B). We also observed that transfer of WT CD4+ T cells or 
Atf6α-deficient CD4+ T cells to WT mice (passive EAE) resulted in similar clinical scores (Fig. 
4C) and histological phenotypes (Fig. 4D). These data support a role for Atf6α in CNS-resident 
cells in mediating EAE severity.  
 




 It is well known that after ligand binding, toll- like receptor 4 (TLR4) recruits several 
adaptors to trigger inflammatory signaling cascades such as NF-κB and Mitogen-activated 
protein kinase (MAPK) pathways (Kawai and Akira, 2007). To investigate whether or not 
these pathways were affected in Atf6α-/- microglia, we challenged cultured microglia with 
lipopolysaccharide (LPS), a potent TLR4 ligand. Western blot analysis revealed that, in the 
NF-κB pathway, the level of both phosphorylated p65 (p-p65) and p65 were significantly 
lower in Atf6α-/- microglia (Fig. 5A). Of note, the effect of Atf6α deletion was somewhat larger 
in the presence of LPS. In contrast, expression of the upstream molecules, such as 
phosphorylated IKKα/β (p-IKKα/β) and IκB, were not different between the two genotypes 
(Fig. 6A), suggesting that p65 may be a direct target of ATF6. In MAPK pathways, by 
contrast, the expression of phosphorylated p38 (p-p38) and phosphorylated ERK1/2 
(p-ERK1/2) were only slightly reduced at the later phase after LPS stimulation (at 60 and 90 
minutes) in Atf6α-/- microglia (Fig. S4). There was no significant difference in the expression of 
phosphorylated JNK (p-JNK) between the two genotypes (Fig. S4). The steady state level of 
p38, ERK1/2 or JNK was not different between two genotypes, suggesting that the stability of 
these molecules was not affected by Atf6α deficiency. 
 Consistent with these results, the level of NF-κB p65 in the nucleus was lower in 
Atf6α-/- microglia than in WT microglia after treatment with LPS, or with other NF-κB 
activators such as IL-1 and TNF (Fig. 5B, C). It is known that TNF is released from 
pathological TH1/TH17 cells, and IL-1 is involved in TH17 differentiation, T cell trafficking 
and CNS tissue damage during the course of EAE (Rodgers and Miller, 2012). Furthermore, 
the binding of NF-κB to its consensus DNA sequence was observed to a lesser extent in Atf6α-/- 
microglia, compared with WT microglia after LPS stimulation (Fig. 5D). Finally, upon LPS 
treatment, Atf6α-/- microglia showed significantly lower induction of NF-κB-associated 




 As proinflammatory genes can be induced by the synergistic effect of LPS and IFN-γ in 
combination via the JAK/STAT signaling pathway (Lowenstein and Padalko, 2004), we 
measured the inflammatory response after treatment with LPS and IFN-γ combinedHowever, 
similar levels of induction of proinflammatory genes was observed in WT and Atf6α-/- 
microglia (Fig. S 4B). 
 
Atf6α deficiency promotes degradation of NF-κB p65 in microglia  
 As previous reports demonstrated a central role of the proteasome in degradation of p65 
(Natoli and Chiocca, 2008; Ono et al., 2015), we hypothesized that Atf6α deficiency might 
promote proteasome-dependent p65 degradation. In fact, treatment of cells with a proteasome 
inhibitor MG132 restored the level of p65 in Atf6α-/- microglia to the similar level observed in 
WT cells (Fig. 6). Collectively, these results suggest that ATF6α may regulate the 






 In the current study, we first demonstrated that the ATF6 pathway is activated in the 
acute phase of EAE. Analysis with WT and Atf6α-/- mice revealed that deletion of Atf6 
suppressed the inflammatory response in microglia/macrophages, and ameliorated 
demyelination and clinical symptoms. BMT experiments and passive EAE revealed that 
CNS-resident cells are responsible for the phenotypes observed in Atf6α-/- mice. Furthermore, 
experiments with cultured cells revealed that deletion of Atf6 promoted p65 degradation in 
the NF-κB signaling pathway in microglia. These results indicate that ATF6 contributes to 
microglial activation and EAE pathology. 
 Microglia are CNS-resident macrophages, whose origins were recently identified as the 
hematopoietic cells of the yolk sac (Prinz et al, 2014). Besides their physiological roles in the 
CNS, they exert pathological functions upon activation (Prinz et al, 2014). In the field of 
MS/EAE, both detrimental and beneficial roles for microglia have been reported, but the 
consensus is that microglia play a pivotal role in MS/EAE pathogenesis, either directly or 
indirectly through the recruitment of other types of cells including the myelin-reactive CD4+ T 
cells (Xiao et al., 2013; Friese et al., 2014; Duffy et al, 2014). Microglia are discriminated from 
monocyte-derived macrophages at least by two methods: separation of CD45hi and CD45lo 
cells by flow cytometry, and development of BM chimera using GFP transgenic mice (Duffy et 
al., 2014). Therefore, we employed both methods in this study. Expression of NOS2 (iNOS), a 
marker of inflammation, was reduced in Atf6-/- mice-derived CD11b+CD45lo cells, but not in 
CD11b+CD45hi cells by flow cytometry after EAE induction (Fig. 3B). Similarly, transfer of 
GFP+WT BM cells to Atf6α-/- mice did not alter the milder phenotype after EAE (Fig. 4A). 
Experiments using cultured cells also revealed that the inflammatory response in microglia, but 




possible, however, that small number of infiltrating macrophages were also affected by the 
deletion of Atf6, and contributed to milder phenotypes after EAE.  
 In the present study, we employed LPS and, in some cases, IL-1, TNF and IFN-γ, to 
induce inflammatory response in cultured microglia. Although LPS may not be involved in the 
microglia-mediated inflammation in MS/EAE, activation of its receptor, toll- like receptor 4 
(TLR4) by endogenous ligands such as fibrinogen, HMGB1, and S100A, collectively termed 
as damage-associated molecular patterns (DAMPs), has been reported to play a critical role in 
the same conditions (for review, Gambuzza et al., 2011). Furthermore, microbial infections are 
an environmental trigger for the onset and persistence of MS, as well as the induction of EAE 
(Xiao et al., 2013) 
  In our model, NF-kB p65 level in the nucleus was relatively lower in IL-1- or 
TNF-treated conditions, compared with that in LPS-treated condition (Fig. 5B, C). This may 
be explained by the fact that each signaling pathway recruits different adaptor molecules to 
activate NF-κB, and, therefore, efficiency may be varied, as previously described (Verstrepen 
et al., 2008).  Regarding IFN-γ, a key cytokine in EAE released from TH1 cells (Rodgers and 
Miller, 2012), deletion of Atf6 did not affect its inflammatory response in cultured microglia 
(Fig. S4 B). The detailed mechanism underlying reduced NF-κB signaling, but not IFN-γ 
signaling, in Atf6-/- microglia remains to be resolved, but it may include enhancement of 
NF-κB p65 degradation through the proteasome (Fig. 6). It is noteworthy that other UPR 
branches, such as PERK and Ire1, were also reported to activate NF-κB signaling through the 
translational suppression of IκB (Deng, et al., 2004; Lin et al., 2013) and the recruitment of 
IKK (Hu et al., 2006), respectively. We propose a scenario wherein each branch of the UPR 
regulates NF-κB signaling by different mechanisms. One of our future studies will therefore be 
to clarify the relationship between ATF6 and the E3 ligases involved in p65 degradation 




deficiency specifically affect microglia during the acute inflammatory stage, we speculate that 
microglia may have a strong demand for UPR at this time to rapidly produce many secreting 
and membrane proteins. 
 In the present study, infiltration of both CD4+ and CD8+ cells, including the 
pathological TH1 cells, was also suppressed in Atf6-/- mice (Fig. 2D, E, F). However, the 
population of T cell-subtypes in peripheral tissues such as the spleen and draining lymph nodes 
was not altered between the two genotypes after EAE (Fig. S2 A). The recall response of 
cultured splenocytes and lymphocytes to MOG35-55 peptide was not changed between the two 
genotypes, either (Fig. S2 C). Finally, adoptive transfer of myelin-reactive CD4+ T cells, 
derived from both genotypes, to WT mice caused comparable phenotypes (Fig. 4 C, D). These 
results suggest that immunoreaction in T cells is not the direct target of ATF6.  
 Previous studies have emphasized important roles of PERK signaling in 
oligodendrocyte survival and remyelination in MS/EAE (Lin and Popko, 2009; Stone and Lin, 
2015). It was also recently reported that deletion of GRP78 in oligodendrocytes caused severe 
impairment in myelination both in physiological and pathological conditions (Hussien et al., 
2015). A recent paper further reported that significant upregulation of ATF6 during 
developmental myelination (Naughton et el., 2015). These observations are in contrast with 
our finding that ATF6 plays a role in the inflammatory response in microglia, and contributes 
to the pathology of EAE. The reason for this discrepancy is currently unknown, but ATF6 
may have both beneficial and detrimental effects, depending on the cell types and timing 
during the pathophysiology in the CNS. To clarify this point, other demyelination models 
without severe immunoreaction and/or other animal models such as oligodendrocyte-specific 
Atf6 knockout mice need to be employed. It is also intriguing to study the role of PERK 





 Our previous studies also indicated that deletion of Atf6α led to suppression of 
astroglial activation and glial scar formation, which were associated with enhanced neuronal 
death in a mouse model of Parkinson’s disease (Hashida et al. 2012) and stroke (Yoshikawa et 
al. 2015). In this study, however, the effect of Atf6α deficiency was not clear in astrocytes (Fig. 
S3 A, B), while enhanced level of KDEL expression was observed in the white matter 
astrocytes after EAE (Fig. 1D). This discrepancy also suggest the limitation of studies using 
systemic knockout mice, but, again, the role of ATF6 may have a different impact, depending 
on the cell types involved and on the pathological conditions.  During the course of EAE, 
inflammation occurs robustly in the CNS from early stage (Fig. 1), while glial scar formation 
was not clearly observed (Fig. S3 A). In contrast, in Parkinson’s disease or stroke model, 
inflammation may occur in more restricted areas such as substantia nigra and caudate putamen, 
or ischemic core region  
 In conclusion, we have demonstrated the pathological role of ATF6 in EAE, which is 
associated with microglial-mediated inflammation through the NF-κB signaling pathway. 
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Figure 1. Expression of UPR-target genes during the course of EAE. A, B, EAE was 
induced in WT (C57BL/6) mice, and total RNA (A) or proteins (B) were extracted from the 
lumbar part of the spinal cord, and subjected to qRT-PCR and western blot, respectively. In A, 
typical results of qRT-PCR using RNA samples (4-8 mice per group) from three independent 
experiments are shown. The values are mean  s.e.m. **P < 0.01, ***P < 0.001 compared to 
control, one-way ANOVA followed by Tukey test. In B, typical results of western blot using 
protein samples (3-4 mice per group) from three independent experiments are shown. The 
values are mean  s.e.m. **P < 0.01, ***P < 0.001 compared to control, Student’s t-test. C, D, 
Spinal cord sections, either from control mice or from EAE mice, were subjected to 
immunohistochemistry with indicated antibodies.  Scale bars: 200 μm (C), 15m (D). The 
typical results of 6 mice from four independent experiments are shown. GM: gray matter, WM: 
white matter. Arrowheads and arrow indicate high and low level of expression of KDEL in 
oligodendrocytes.  
 
Figure 2. Reduced severity in Atf6 -/- mice after induction of EAE. A, Mean clinical 
scores in WT and Atf6α -/- mice after induction of EAE. Twelve WT mice and 13 Atf6α -/- mice 
from three independent experiments (4-5 mice/group) were analyzed. The values are mean  
s.e.m. ***P < 0.0001 between two genotypes, two-way ANOVA. B, C, H&E staining (B) and 
immunohistochemistry (C) of the spinal cord at the acute phase of EAE. Note that, the invasion 
of inflammatory cells and demyelination were reduced in Atf6α -/- mice at the acute phase of 
EAE. Scale bars: 50 μm. Two slices per mouse and four mice per genotype from three 
independent experiments were analyzed. The values are mean  s.e.m. *P < 0.05 between two 




CNS of WT and Atf6 -/- mice at the acute phase of EAE. Seven mice per genotype from four 
independent experiments (D) and 5 mice per genotype from three independent experiments (E, 
F) were analyzed. The numbers in the plots indicate the percentages of each gated cell 
population among the total CNS-infiltrating cells (D). Both of the percentage and the absolute 
number of the CNS-infiltrating cells (D) and IFN-γ+ or IL-17+CD4+ T cells (E, F) in the CNS of 
both genotypes are shown. The values shown are the mean  s.e.m. *P < 0.05, **P < 0.01 
between two genotypes, Student’s t-test.  
 
Figure 3. Impaired microglia/macrophage activation in Atf6 -/- mice after induction of 
EAE. A, Immunohistochemistry of the spinal cord in the control and at the acute phase of EAE. 
Spinal cord sections from WT and Atf6α -/- mice both under control and EAE conditions were 
prepared, and subjected to immunohistochemistry for Iba1. Scale bars: 200μm at low 
magnification and 25m at high magnification. Two slices per mouse and six mice per 
genotype from three independent experiments were analyzed. The values shown are the mean 
 s.e.m. ***P < 0.001 between two genotypes, Student’s t-test. B, Flow cytometry analysis of 
microglia and macrophages in the CNS from WT and Atf6 -/- mice at the acute phase of EAE. 
The percentage of NOS2+ cells are shown. Three mice per genotype from three independent 
experiments were analyzed. The values shown are the mean  s.e.m. *P < 0.05 between two 
genotypes, Student’s t-test. C, Immunohistochemical analysis of NF-κB p65 in white matter of 
the spinal cord after EAE. The spinal cord from WT and Atf6 -/- mice at the acute phase of 
EAE was subjected to immunohistochemistry for p65 and Iba1. Note that the ratio of NF-κB 
p65+Iba1+ cells versus Iba1+ cells was much lower in Atf6 -/- microglia. Scale bars: 50μm Two 
slices per mouse and six mice per genotype from three independent experiments were analyzed. 






Figure 4. Bone marrow transfer (BMT) experiments and adoptive transfer of 
autoimmune CD4+ T cells to recipient mice (passive EAE). A, B, BMT. Lethally irradiated 
WT and Atf6α -/- mice received BMT from GFP+WT mice, and EAE was induced after their 
recovery. Eight WT mice and 7 Atf6α -/- mice were analyzed from two independent 
experiments. A, Mean clinical scores are indicated as mean value  s.e.m. *P < 0.05 between 
two genotypes, two-way ANOVA. B, Spinal cords from WT and Atf6α -/- mice after BMT/EAE 
were subjected to immunohistochemistry for GFP. Scale bars: 200μm. C, D, Passive EAE. 
Restimulated CD4+ T cells, derived from both WT and Atf6 -/- mice, were transferred to 
sublethally irradiated WT recipient mice. Four mice per genotype were analyzed from two 
independent experiments. C, Mean clinical scores are indicated as mean value  s.e.m. *P < 
0.05 between two genotypes, two-way ANOVA. D, Spinal cords from WT and Atf6α -/- mice 
after passive EAE were subjected to H&E staining. Scale bars: 200μm.  
 
Figure 5. Impaired signal transduction of the NF-κB pathway in Atf6 -/- microglia. A, 
Western blot analysis of the NF-κB pathway. Whole cell lysates from cultured WT and Atf6 -/- 
microglia stimulated with LPS (100 ng/ml) for the indicated times were subjected to western 
blot for the indicated molecules. Values shown are the mean  s.e.m. from three independent 
experiments. *P < 0.05, **P < 0.01 between two genotypes, Student’s t-test. B, C, 
Immunocytochemical analysis of NF-κB p65. Cultured WT and Atf6 -/- microglia were 
stimulated with LPS (100 ng/ml) for 1h, IL-1 (100 ng/ml) for 1h, or TNF (20 ng/ml) for 
30min, and, after fixation, subjected to immunocytochemistry for p65 and Iba1. Scale bars: 
20μm. In C, the intensity of p65 in the nucleus was quantified, as described in Materials and 
Methods. Ninety cells per condition from three independent experiments were analyzed. 




followed by Tukey test. D, Binding of NF-κB to its consensus DNA sequence.  The binding of 
NF-κB to its consensus DNA sequence was measured as described in the text. Results from 
four independent experiments are shown. Values are the mean  s.e.m. *P < 0.05, compared 
with untreated condition, one-way ANOVA followed by Tukey test.  E, Induction of NF-κB 
downstream genes in cultured WT and Atf6 -/- microglia. Cells were stimulated with LPS (100 
ng/ml) the indicated times, and total RNA was subjected to qRT-PCR analysis. The values 
shown are the mean  s.e.m. from three independent experiments. **P < 0.01 between two 
genotypes, Student’s t-test. 
 
Figure 6. Proteasome-dependent degradation of NF-κB p65 in Atf6 -/- microglia. Whole 
cell lysates from WT and Atf6 -/- microglia stimulated with LPS (100 ng/ml) with/without 
MG132 (10 M) for 60 min were subjected to western blot for the indicated molecules. Values 
shown are the mean  s.e.m. from three independent experiments. *P < 0.05, **P < 0.01, 







Atf6α deficiency suppresses microglial activation and ameliorates pathology 
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Supplemental Figure Legends 
Figure S1. Expression of GRP78 and GRP94 in the chronic phase of EAE. Proteins samples 
were extracted from the lumbar part of the spinal cord of WT mice, and subjected to western blot. Typical 
results (3-4 mice per group) from three independent experiments are shown. The values are 
mean  s.e.m. **P < 0.01, ***P < 0.001 compared to control, Student’s t-test. 
 
Figure S2. Activation status of lymphocytes in WT and Atf6 -/- mice. A, B, Flow 
cytometric analysis of lymphocytes from peripheral tissues at the acute phase of EAE. Five 
mice per genotype from three independent experiments were analyzed. The percentage and the 
absolute number of lymphocyte population (A) and that of IFN-γ+CD4+ or IL-17+CD4+ T cells 
(B) are shown. The values shown are the mean  s.e.m. ns, not significant, Student’s t-test. C, 
Recall response of splenocytes and lymphocytes against the MOG35-55 peptide. Isolated 
splenocytes and lymphocytes were re-stimulated with MOG35-55 for 3 days, and then subjected 
to BrdU incorporation assay (C). The values shown are the mean  s.e.m. one-way ANOVA 
followed by Tukey test. Three mice per genotypes from three independent experiments were 





Figure S3. Activation status of astrocytes in vivo and in vitro. A, Immunohistochemistry of 
the spinal cord in the control and at the acute phase of EAE. Spinal cord sections from WT and 
Atf6α -/- mice under both control and acute EAE conditions, subjected to 
immunohistochemistry for GFAP. Two slices per mouse and four mice per genotype from two 
independent experiments were analyzed. Scale bars: 200 μm at low magnification and 25m at 
high magnification. B, WT and Atf6 -/- astrocytes in culture were stimulated with LPS (100 
ng/ml), or incubated in the medium alone (untreated) for 16 h, and total RNA was subjected to 
qRT-PCR analysis for proinflammatory gene expression. Values shown are the mean  s.e.m. 
from three independent experiments.  
 
Figure S4. Signal transduction of the MAPK pathway after LPS treatment and induction 
of NF-κB downstream genes after IFNγ treatment in microglia. A, Whole cell lysates from 
WT and Atf6 -/- microglia, stimulated with LPS (100 ng/ml) for the indicated times were 
subjected to western blot for the indicated molecules. Values shown are the mean  s.e.m. from 
three independent experiments. *P < 0.05, **P < 0.01, Student’s t-test. B, WT and Atf6 -/- 
microglia were stimulated with LPS (100 ng/ml) and IFN-γ (20 ng/ml), and total RNA was 
subjected to qRT-PCR analysis for proinflammatory gene expression. The values shown are 
the mean  s.e.m. from three independent experiments. ns: not significant, Student’s t-test. 
 
Figure S5. Immunohistochemistry of the spinal cord at the acute phase of EAE. Different 






























































































































































































































































































































































































































































































































































































































p65 Iba1 DAPI p65 Iba1 DAPIDAPI p65 DAPI p65

















































































- + - +






- + - + - + - +
























































































































































































































































































WT Atf6α-/- WT Atf6α-/-
EAEControl
B









































































































0 15 30 60
WT





































































     (h)
0 6 16
LPS+IFN-γ
     (h)
N
os
2 
/ G
ap
dh
C
cl
2 
/ G
ap
dh
C
cl
8 
/ G
ap
dh
WT
Atf6α-/- 
nsnsns
ns
ns
ns
A
Fig. S5
W
T-
E
A
E
At
f6
α-
/-
E
A
E
MBP/CD45CD45MBP
CD45MBP MBP/CD45
